Experimental acute pancreatitis results in increased blood-brain barrier permeability in the rat: A potential role for tumor necrosis factor and interleukin 6

Neuroscience Letters

Volumn 242, Issue 3, 1998, Pages 147-150

  Farkas, Gyula ^a   Márton, János ^a   Nagy, Zsuzsanna ^a   Mándi, Yvette ^a   Takács, Tamás ^a   Deli, Mária A ^b   Ábrahám, Csongor S ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF BIOCHEMISTRY   (Hungary)

Author keywords

Acute pancreatitis; Blood brain barrier; Brain edema; Encephalopathy; Interleukin 6; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; CEREBELLUM; CORPUS STRIATUM; HIPPOCAMPUS; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT;

AMYLASES; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN EDEMA; CHOLAGOGUES AND CHOLERETICS; DISEASE MODELS, ANIMAL; ENCEPHALITIS; EVANS BLUE; FLUORESCEIN; INTERLEUKIN-6; MALE; ORGAN SIZE; PANCREAS; PANCREATITIS, ACUTE NECROTIZING; RATS; RATS, WISTAR; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344701055     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00060-3     Document Type: Article

References (33)

1. Ábrahám C.S., Deli M.A., Joó F., Megyeri P., Torpier G. Intracarotid tumor necrosis factor-α administration increases the blood-brain barrier permeability in the cerebral cortex of newborn pig: quantitative aspects of double-labelling studies and confocal laser scanning analysis. Neurosci. Lett. 208:1996;85-88.
2. Aho H.J., Koskensalo S.M.-L., Nevalainen T.J. Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. Scand. J. Gastroenterol. 15:1980;411-416.
3. Arden L.A., deGroot E.R., Shaap O.L. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 17:1987;1411-1416.
4. Banks W.A., Kastin A.J., Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 179:1994;53-56.
5. Beutler B., Grau G.E. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21:1993;S423-S435.
6. Boon P., de Reuck J., Achten E., de Bleecker J. Pancreatic encephalopathy. A case report and review of the literature. Clin. Neurol. Neurosurg. 93:1991;137-141.
7. Brett F.M., Mizisin A.P., Powell H.C., Campbell I.L. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J. Neuropathol. Exp. Neurol. 54:1995;766-775.
8. Ceska M., Birath K., Brown B. A new and rapid method for the clinical determination of amylase activities in human serum and urine. Clin. Chim. Acta. 26:1969;437-444.
9. Deli M.A., Descamps L., Dehouck M.-P., Cecchelli R., Joó F., Ábrahám C.S., Torpier G. Exposure of tumor necrosis factor-α to the luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J. Neurosci. Res. 41:1995;717-726.
10. de Vries H.E., Blom-Roosemalen M.C., van Oosten M., de Boer A.G., van Berkel T.J., Breimer D.D., Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64:1996;37-43.
11. Espevik T., Niessen-Meyer J.A. A highly sensitive cell line WEHI 164 for measuring cytotoxic factor/tumor necrosis factor. J. Immunol. Methods. 95:1986;99-105.
12. Estrada R.V., Moreno J., Martinez E., Hernandez M.C., Gilsanz G., Gilsanz V. Pancreatic encephalopathy, Acta Neurol. Scand. 59:1979;135-139.
13. Exley A.R., Leese T., Holliday M.P. Endotoxaemia and serum tumor necrosis factor as prognostic markers in severe acute pancreatitis. Gut. 33:1992;1126-1128.
14. Farkas, Gy., Mándi, Y. and Márton, J., Modification of cytokine production in septic condition following necrotizing pancreatitis. In L. Papastamatiou (Ed.), European I.H.P.B.A. Congress Athens 1995, Monduzzi Editore, Bologna, 1996, pp. 609-613.
15. Feuerstein G.Z., Liu T., Barone F.C. Cytokines, inflammation, and brain injury: role of tumor necrosis-alpha. Cerebrovasc. Brain Metab. Rev. 6:1994;341-360.
16. Gross V., Lese H.-G., Heinisch A. Inflammatory mediators and cytokines - new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatol. Gastroenterol. 40:1993;522-530.
17. Gutierrez E.G., Banks W.A., Kastin A.J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47:1993;169-176.
18. Heath D.I., Cruickshank A., Gudgeon M. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut. 34:1993;41-45.
19. Hirohata S., Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 33:1990;644-649.
20. Laurenzi M.A., Siden A., Persson M.A., Norkrans G., Hagberg L., Chiodi F. Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system. Clin. Immunol. Immunopathol. 57:1990;233-241.
21. Mándi Y., Farkas Gy., Ocsovszky I., Nagy Z. Inhibition of tumor necrosis factor production and ICAM-1 expression by pentoxifylline: beneficial effects in sepsis syndrome. Res. Exp. Med. 195:1995;297-307.
22. McKay C., Gallagher G., Baxter J.N. Systemic complications in acute pancreatitis are associated with increased monocyte cytokine release. Gut. 35:1994;574-576.
23. Megyeri P., Ábrahám C.S., Temesvári P., Kovács J., Vas T., Speer C.P. Recombinant human tumor necrosis factor α constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci. Lett. 148:1992;137-140.
24. Mintz M., Rapaport R., Oleske J.M., Connor E.M., Koenigsberger R., Denny T., Epstein L.G. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am. J. Dis. Child. 143:1989;771-774.
25. Norman J.G., Franz M., Fink G.S. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann. Surg. 6:1995;625-634.
26. Ott L., McClain C.J., Gillespie M., Young B. Cytokines and metabolic dysfunction after severe head injury. J. Neurotrauma. 11:1994;447-472.
27. Saez Royula-Gonzalo F., Gomez-Rodriguez R., Gomez-Rubio M., Heredia-Centeno M., Miranda-Baiochi R., Hernandez-Guio C. Complications of acute pancreatitis. Frequency, moment of onset and multiplicity. Rev. Clin. Esp. 184:1989;280-284.
28. Saija A., Princi P., Lanza M., Scalese M., Aramnejad E., De Sarro A. Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci. 56:1995;775-784.
29. Sharief M.K., Thompson E.J. In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis. J. Neuroimmunol. 38:1992;27-32.
30. Takács T., Farkas Gy. Jr., Czakó L., Jármay K., Mándi Y., Lonovics J. Time-course changes in serum cytokine levels in two experimental acute pancreatitis models in rats. Res. Exp. Med. 196:1996;153-161.
31. Viedma J.A., Perz-Mateo M., Dominguez J.E. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut. 33:1992;1264-1267.
32. Wang X.D., Deng X.M., Haraldsen P., Andersson R., Ihse I. Antioxidant and calcium channel blockers counteract endothelial barrier injury induced by acute pancreatitis in rats. Scand. J. Gastroenterol. 30:1995;1129-1136.
33. Winslet M.C., Donovon I.A., Aitchison F. Wernicke's encephalopathy in association with complicated acute pancreatitis and morbid obesity. Br. J. Clin. Pract. 44:1990;771-773.